Biological Characterization of Novel Inhibitors of the Gram-Positive DNA Polymerase IIIC Enzyme
AUTOR(ES)
Kuhl, Alexander
FONTE
American Society for Microbiology
RESUMO
Novel N-3-alkylated 6-anilinouracils have been identified as potent and selective inhibitors of bacterial DNA polymerase IIIC, the enzyme essential for the replication of chromosomal DNA in gram-positive bacteria. A nonradioactive assay measuring the enzymatic activity of the DNA polymerase IIIC in gram-positive bacteria has been assembled. The 6-anilinouracils described inhibited the polymerase IIIC enzyme at concentrations in the nanomolar range in this assay and displayed good in vitro activity (according to their MICs) against staphylococci, streptococci, and enterococci. The MICs of the most potent derivatives were about 4 μg/ml for this panel of bacteria. The 50% effective dose of the best compound (6-[(3-ethyl-4-methylphenyl)amino]-3-{[1-(isoxazol-5-ylcarbonyl)piperidin-4-yl]methyl}uracil) was 10 mg/kg of body weight after intravenous application in a staphylococcal sepsis model in mice, from which in vivo pharmacokinetic data were also acquired.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=549236Documentos Relacionados
- Inhibitors of DNA Polymerase III as Novel Antimicrobial Agents against Gram-Positive Eubacteria
- In Vitro Antimicrobial Activities of Novel Anilinouracils Which Selectively Inhibit DNA Polymerase III of Gram-Positive Bacteria
- Characterization of unusual tetracycline-resistant gram-positive bacteria.
- In Vitro Activities of Peptide Deformylase Inhibitors against Gram-Positive Pathogens
- Hemophilic Gram-positive Rods